Product
Standard Dose Quadrivalent Influenza Vaccine
1 clinical trial
3 indications
Indication
InfluenzaIndication
Influenza-like IllnessIndication
HumanClinical trial
Comparative Effectiveness of Recombinant Versus Standard Dose Quadrivalent Influenza Vaccine in U.S. Nursing HomesStatus: Active (not recruiting), Estimated PCD: 2023-08-01